Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sernova Corp. buy stockpicking

Start price
€0.87
13.10.21 / 100%
Target price
€10.00
13.10.24
Performance (%)
-4.83%
End price
€0.83
15.06.22
Summary
This prediction ended on 15.06.22 with a price of €0.83. With a performance of -4.83%, the BUY prediction for Sernova Corp. by stockpicking closed slightly in the red. stockpicking has 100% into this prediction

Sernova Corp (WKN A0LBCR) is an innovative biotechnology company specializing in the development of regenerative medicine therapies. Focused on improving the treatment of chronic diseases, Sernova utilizes its proprietary Cell Pouch System™ - an implantable and scalable medical device - to house therapeutic cells for the long-term treatment of metabolic, hematologic, and neurological disorders. Listed on various stock exchanges, including Canada's TSX Venture Exchange (TSX-V), the Frankfurt Stock Exchange (FRA), and U.S. OTC (OTC:SEOVF), Sernova is driven by a mission to dramatically improve the outcomes and lives of individuals living with chronic diseases, while simultaneously offering a lucrative investment opportunity for those that believe in the potential of regenerative medicine.

Performance without dividends (%)
Name 1w 1m 1y
Sernova Corp. -12.867% -12.867% -46.621%
iShares Core DAX® -1.670% -1.001% 10.864%
iShares Nasdaq 100 -4.184% -1.145% 37.458%
iShares Nikkei 225® -4.967% -5.783% 18.828%
iShares S&P 500 -2.834% -0.572% 25.875%

According to stockpicking what are the pros and cons of Sernova Corp. for the foreseeable future?

Pros
Leading role in innovation
Capable Management
Good culture
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Small cyclical dependencies
Market Leader or Top 3
Very Future proof/growth oriented business model
Small Risks for its business
Known brand
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Undervalued
Very high dividend yield expected
Very positive Cash Flow expected
Top Rating
High Investments for future growth
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Management is a major shareholder
Sustainability is important
Cons

Comments by stockpicking for this prediction

In the thread Sernova Corp. diskutieren
Prediction Buy
Perf. (%) -4.83%
Target price 13.000
Change
Ends at

Buy mit Kursziel 13,0

Prediction Buy
Perf. (%) -4.83%
Target price 12.000
Change
Ends at 13.10.24

Kursziel geändert auf 12,0

Prediction Buy
Perf. (%) -4.83%
Target price 10.000
Change
Ends at 13.10.24

Kursziel geändert auf 10,0

Stopped prediction by stockpicking for Sernova Corp.

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques